"We are very pleased to have secured an investment grade rating from S&P, which reflects our strong financial position," stated Johan Adebäck, Elekta's CFO. "This rating gives us even better potential to seek additional market financing at attractive terms, and it will support our strategy ACCESS 2025 in driving sustainable profitable growth and close the global access gap to radiotherapy, elevating cancer care and increasing patients' participation in their own care."
# # #
For further information, please contact:
Tel: +46 76 611 76 25, e-mail: cecilia.ketels@elekta.com
Time zone: CET (Central European Time)
Tel: +46 70 865 8012, e-mail: Mattias.Thorsson@elekta.com
Time zone: CET: Central European Time
This is information that
About Elekta
As a leader in precision radiation therapy, Elekta is committed to ensuring every patient has access to the best cancer care possible. We openly collaborate with customers to advance sustainable, outcome-driven and cost-efficient solutions to meet evolving patient needs, improve lives and bring hope to everyone dealing with cancer. To us, it's personal, and our global team of 4,700 employees combine passion, science, and imagination to profoundly change cancer care. We don't just build technology, we build hope. Elekta is headquartered in
https://news.cision.com/elekta/r/elekta-receives-initial-investment-grade-rating-from-s-p-global-ratings,c3440528
https://mb.cision.com/Main/35/3440528/1486502.pdf
(c) 2021 Cision. All rights reserved., source